Interim CEO Named Permanent Leader at Tango Therapeutics Post author:Sam Post published:September 24, 2017 Post category:BioPharma September 25, 2017By Mark Terry, BioSpace.com Breaking News… Source: BioSpace You Might Also Like 19 Deaths, Serious Liver Injury Linked to Intercept Pharma's Ocaliva September 21, 2017 Teligent Announces FDA Approval Of Erythromycin Topical Gel USP, 2% July 20, 2017 Cytokinetics To Announce First Quarter Results On April 27, 2017 April 13, 2017
